ANDREW WEIL ON THE RISKS AND BENFITS OF MEDICAL MARIJUANA
(from the Arizona Daily Star, June, 2002)
(Editor.s note: this article was published just prior to the June 6th DEA protests across the nation.)
"On Thursday, in dozens of cities and towns across the United States, something remarkable will happen: Thousands of people battling cancer, AIDS and other terrible illnesses, their families, friends and supporters will deliver "cease and desist" orders to the federal Drug Enforcement Administration to stop it from blocking their access to a needed medication.
Their request is so simple and so obviously correct that it is heartbreaking that people - many very seriously ill - will be forced to deliver their message this way, with many risking arrest.
But as individuals who have found that medical marijuana relieves their symptoms when conventional medicines fail, they feel they have no choice: The federal government continues to fight an irrational war against
Medical marijuana, and the sick and struggling are its principle victims. Make no mistake: The government's demonization of marijuana is irrational..."
http://www.cannabismd.org/news/mmjbennies.phpHere's a website containing links to REAL scientific studies on various benefits of marijuana. Here are the highlights:
The Studies
Marijuana Fights:
Heart Disease
Cancer
Diabetes
Osteoporosis
Alzheimer's
Liver Disease
Epilepsy
Skin Allergies
Post Traumatic Stress Disorder
Anxiety and Depression
and is also Neuroprotective and Causes Neurogenesis (brain cell growth)
http://www.scientificfactsofpot.com/studies.htmCannabis Compounds Reduce Multi-Drug Resistant Infections
Cannabis Science, Inc. (OTCBB: GFON). Dr. Robert Melamede, PhD., Director and Chief Science Officer, reported to the Board on the current state of research into the use of natural plant cannabinoids to reduce the spread of drug-resistant bacteria, including methicillin-resistant Staphyloccus aureus (MRSA), and the prospects for development of topical whole-cannabis treatments.
According to studies published in the Journal of the American Medical Association and by the Center for Disease Control in 2007, MRSA is responsible for more than 18,500 hospital-stay related deaths each year, and increased direct healthcare costs of as much as $9.7 billion.
Dr. Melamede stated, "Research into use of whole cannabis extracts and multi-cannabinoid compounds has provided the scientific rationale for medical marijuana's efficacy in treating some of the most troubling diseases mankind now faces, including infectious diseases such as the flu and HIV, autoimmune diseases such as ALS (Lou Gehrig's Disease), multiple sclerosis, arthritis, and diabetes, neurological conditions such as Alzheimer's, stroke and brain injury, as well as numerous forms of cancer. One common element of these diseases is that patients often suffer extended hospital stays, risking development of various Staphyloccus infections including MRSA. A topical, whole-cannabis treatment for these infections is a functional complement to our cannabis extract-based lozenge."
Investigators at Italy's Universita del Piemonte Orientale and Britain's University of London, School of Pharmacy reported in the Journal of Natural Products that five cannabinoids - THC, CBD, CBG, CBC, and CBN - "showed potent antibacterial activity" and "exceptional" antibacterial activity against two epidemic MRSA occurring in UK hospitals. The authors concluded: "Although the use of cannabinoids as systemic antibacterial agents awaits rigorous clinical trials, … their topical application to reduce skin colonization by MRSA seems promising. … Cannabis sativa … represents an interesting source of antibacterial agents to address the problem of multidrug resistance in MRSA and other pathogenic bacteria."
More:
http://www.medicalnewstoday.com/articles/147523.phpUniversity Of Saskatchewan Research Suggests Marijuana Analogue Stimulates Brain Cell Growth
ScienceDaily (Oct. 16, 2005) — A synthetic substance similar to ones found in marijuana stimulates cell growth in regions of the brain associated with anxiety and depression, pointing the way for new treatments for these diseases, according to University of Saskatchewan medical research published today in The Journal of Clinical Investigation.
Xia Zhang, an associate professor in the U of S neuropsychiatry research unit, led the team that tested the effects of HU-210, a potent synthetic cannabinoid similar to a group of compounds found in marijuana. The synthetic version is about 100 times as powerful as THC, the compound responsible for the high experienced by recreational users.
The team found that rats treated with HU-210 on a regular basis showed neurogenesis – the growth of new brain cells in the hippocampus. This region of the brain is associated with learning and memory, as well as anxiety and depression.
The effect is the opposite of most legal and illicit drugs such as alcohol, nicotine, heroin, and cocaine.
“Most ‘drugs of abuse’ suppress neurogenesis,” Zhang says. “Only marijuana promotes neurogenesis.”
Current theory states that depression may be sparked when too few new brain cells are grown in the hippocampus. It is unclear whether anxiety is part of this process, but if true, HU-210 could offer a treatment for both mood disorders by stimulating the growth of new brain cells.
But Zhang cautions that HU-210 is only one of many cannabinoids. His previous work with marijuana shows that while the plant may contain medicinal compounds, they come in the same package as those that cause symptoms such as acute memory impairment, addiction, and withdrawal. Also, the HU-210 used in the study is highly purified.
“This is a very potent cannabinoid oil,” Zhang says. “It’s not something that would be available on the street.”
Adapted from materials provided by University Of Saskatchewan.
Scientists are high on idea that marijuana reduces memory impairment
COLUMBUS, Ohio – The more research they do, the more evidence Ohio State University scientists find that specific elements of marijuana can be good for the aging brain by reducing inflammation there and possibly even stimulating the formation of new brain cells.
The research suggests that the development of a legal drug that contains certain properties similar to those in marijuana might help prevent or delay the onset of Alzheimer's disease. Though the exact cause of Alzheimer's remains unknown, chronic inflammation in the brain is believed to contribute to memory impairment.
Any new drug's properties would resemble those of tetrahydrocannabinol, or THC, the main psychoactive substance in the cannabis plant, but would not share its high-producing effects. THC joins nicotine, alcohol and caffeine as agents that, in moderation, have shown some protection against inflammation in the brain that might translate to better memory late in life.
"It's not that everything immoral is good for the brain. It's just that there are some substances that millions of people for thousands of years have used in billions of doses, and we're noticing there's a little signal above all the noise," said Gary Wenk, professor of psychology at Ohio State and principal investigator on the research. Wenk's work has already shown that a THC-like synthetic drug can improve memory in animals. Now his team is trying to find out exactly how it works in the brain...
Contact: Gary Wenk, (614) 688-3404; Wenk.6@osu.edu or Yannick Marchalant, (614) 688-4699; Marchalant.1@osu.edu
Written by Emily Caldwell, (614) 292-8310; Caldwell.151@osu.edu
Marijuana May Fight Lung Tumors
Cannabis Compound Slows Cancer Spread in Mice, Researchers Say
By Charlene Laino
WebMD Health News
Reviewed by Louise Chang, MD
April 17, 2007 (Los Angeles) -- Cannabis may be bad for the lungs, but the active ingredient in marijuana may help combat lung cancer, new research suggests.
In lab and mouse studies, the compound, known as THC, cut lung tumor growth in half and helped prevent the cancer from spreading, says Anju Preet, PhD, a Harvard University researcher in Boston who tested the chemical.
While a lot more work needs to be done, “the results suggest THC has therapeutic potential,” she tells WebMD.
Moreover, other early research suggests the cannabis compound could help fight brain, prostate, and skin cancers as well, Preet says.
The findings were presented at the annual meeting of the American Association for Cancer Research.
View Article Sources
© 2007 WebMD, Inc. All rights reserved.
Just my dos centavos
robdogbucky